Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P243
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sato-Matsushita, Marimo
Hayakawa, Yoshihiro
Asami, Asuka
Nakayama, Setsuko
Tahara, Hideaki
Article History
First Online: 4 November 2015